Search results
If you are located in the states of California, Colorado, Washington, or DC, and are looking for support in safely discontinuing an antidepressant medication,
Antidepressant withdrawal from both sides of the desk. Update: A publication date has just been announced for our handbook on how to safely stop psychiatric drugs called the Maudsley Deprescribing Guidelines. It will be published in the UK and Europe on the 15th of February, 2024 as a paperback (already available as a kindle version) and in the ...
Dr Mark Horowitz MBBS PhD is is the founder of the Psychiatric Drug Deprescribing Clinic at North East London NHS Foundation Trust, Clinical Research Fellow in Psychiatry at North East London NHS Foundation Trust (NELFT), Visiting Lecturer at King’s College London, an Honorary Clinical Research Fellow at University College London, and co-founder of Outro Health, a medical deprescribing service.
Podcast; Turning the Tide on Overmedication: Dr. Mark Horowitz’s Approach to Deprescribing, Part 1 May 14, 2024 Dr. Mark Horowitz, a Clinical Research Fellow in Psychiatry from the UK and co-author of “The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs,” delves into the complexities of deprescribing psychiatric medications such as ...
Dr. Horowitz is a neuroscientist, a Clinical Research Fellow in Psychiatry at the National Health Service in England, and a world-leading researcher in psychiatric medication deprescribing. Mark co-wrote the Royal College of Psychiatrists' guidelines on antidepressant discontinuation, based on the p
Dr Mark Horowitz MBBS PhD is Clinical Research Fellow in Psychiatry at North East London NHS Foundation Trust (NELFT), an Honorary Clinical Research Fellow at University College London and a training psychiatrist. He has been commissioned by Health Education England to prepare a teaching module on how to safely stop antidepressants. He co ...
The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition. A Guy, M Brown, S Lewis, M Horowitz. Therapeutic Advances in Psychopharmacology 10, 2045125320967183. , 2020. 61.
